Use of intravenous antiarrhythmics to identify concealed Brugada syndrome
<p>Abstract</p> <p>Cardiology has recently witnessed the production of an overwhelming amount of data through the advances made in genetics and molecular biology research. Understanding of genetics has tremendous potential to aid in the prevention, diagnosis and treatment of the ma...
Main Author: | Brugada Ramon |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2000-08-01
|
Series: | Current Controlled Trials in Cardiovascular Medicine |
Subjects: | |
Online Access: | http://cvm.controlled-trials.com/content/1/1/045 |
Similar Items
-
Genetic and Molecular Mechanisms in Brugada Syndrome
by: Errol Moras, et al.
Published: (2023-07-01) -
Prevalence and prognosis of patients with lone and paroxysmal atrial tachyarrhythmias showing Brugada-type electrocardiograms after class IC antiarrhythmic drug administration but no risk-stratifying factors
by: Atsuko Abe, MD, et al.
Published: (2013-04-01) -
Prevalence and Clinical Significance of Latent Brugada Syndrome in Atrial Fibrillation Patients Below 45 Years of Age
by: Ramadan Ghaleb, et al.
Published: (2020-11-01) -
Brugada Syndrome within Asian Populations: State-of-the-Art Review
by: Muzamil Khawaja, et al.
Published: (2023-04-01) -
Brugada syndrome in children - Stepping into unchartered territory
by: Shashank P Behere, et al.
Published: (2017-01-01)